Tendonitis - Epidemiology Forecast - 2030

DelveInsight’s "Tendonitis - Epidemiology Forecast-2032" report delivers an in-depth understanding of the disease, historical and forecasted Tendonitis epidemiology in the 7MM, i.e., the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.
Tendonitis Understanding
Tendonitis is an inflammation of a tendon – a thick, flexible cord of tissue that attaches muscles to bone and assists in moving the bone or structure. Tendonitis most commonly occurs in the shoulder, bicep, elbow, hand, wrist, thumb, calf, knee, or ankle. Since the pain of tendonitis occurs near a joint, it is sometimes mistaken for arthritis. The condition is more common in adults over the age of 40 and athletes. Some forms of tendonitis are named after certain sports (e.g., tennis elbow, golfer’s elbow, pitcher’s shoulder, swimmer’s shoulder, and jumper’s knee).
Tendonitis often results from sports injuries or repetitive movements. However, it can also be caused by: bad posture or walking habits; an infection; stress on soft tissues from an abnormal or poorly positioned joint or bone (such as leg length differences or joint deformities); some types of arthritis and related conditions (rheumatoid arthritis, osteoarthritis, and gout); metabolic conditions, such as diabetes; and side effects from certain medications (e.g., fluoroquinolone antibiotics and statins drugs) though this is very rare.
Tendonitis causes inflammation, tenderness, and pain in areas around a joint, such as the tendons, ligaments, and muscles. Some types of tendonitis can occur suddenly, last for days or longer. The pain is worse with movement and usually gets better with rest or treatment. Tendonitis symptoms can re-occur in the same area of the body.
Tendonitis Diagnosis
The first step in the diagnosis of tendonitis is performing a comprehensive evaluation. If there is tenderness at one specific point in the tendon, this can indicate tendonitis. If the problem does not go away with rest, ice, and over-the-counter (OTC) medications, the doctor may recommend some tests and consider all possible causes of the symptoms, and then use special imaging tests to help to get an accurate diagnosis.
Medical history: The doctor asks many questions about the patient’s health history and current exercise habits and then describes the pain and how it changes with activity and rest. Physical exam: The injured area is examined by moving it in certain ways to check for areas of tenderness and test the range of motion. Attempts are made to rule out other sports injuries, such as an inflammation of the fluid-filled sacs near the tendons (bursitis). X-rays: Although X-rays do not show tendons, these tests can help rule out other medical conditions, such as bone problems. An x-ray can show calcium deposits around the tendon, which may help confirm a diagnosis. A small amount of radiation is used to make an image. Tendons cannot be seen on an X-ray, but they can show bone.
Other imaging tests, such as ultrasound or MRI, may reveal swelling of the tendon sheath. Magnetic resonance imaging (MRI): If there is a partial tendon tear, MRI may be ordered to examine the area more closely. Testing for infection: On rare occasions, tendonitis can be caused by infections. The doctor may order blood tests or remove a fluid sample from the inflamed area to rule out an infection. Ultrasound: This test uses sound waves to produce images of the soft tissue structures within and around the micro-tear area. Soft-tissue structures include joints, ligaments, and tendons, which are not easy to see using other tests.
Epidemiology Perspective by DelveInsight
The Tendonitis epidemiology division provides insights about historical and current Tendonitis patient pool and forecasted trends for every seven major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the DelveInsight report also provides the diagnosed patient pool and their trends along with assumptions undertaken.
Key Findings
In the year 2020, the total incident cases of Tendonitis was 11.71 million cases in the 7MM which are expected to grow during the study period, i.e., 2018–2030.
The disease epidemiology covered in the report provides historical as well as forecasted Tendonitis epidemiology [segmented as Total Incident Cases of Tendonitis, Total Gender-specific Cases of Tendonitis, Total region-specific Cases of Tendonitis, and Total Treated Cases of Tendonitis] in the 7MM covering the United States, EU5 countries (Germany, France, Italy, Spain, and the United Kingdom), and Japan from 2018 to 2030.
Country Wise- Tendonitis Epidemiology
Estimates show that the highest cases of Tendonitis in the 7MM were in the United States, followed by Japan, France, the United Kingdom, Italy, Germany, and Spain in 2020.
 In the United States, the total number of incident cases of Tendonitis was 4.77 million cases in the year 2020 which are expected to grow during the study period, i.e., 2018–2030.
 In the year 2020, the total incident cases of Tendonitis were 0.17 million cases in Spain which are expected to grow during the study period, i.e., 2018–2030.
 In Japan, the total number of incident cases of Tendonitis was 1.99 million cases in the year 2020 which are expected to grow during the study period, i.e., 2018–2030.
Scope of the Report
• The Tendonitis report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis, and treatment patterns.
• The Tendonitis Report and Model provide an overview of the risk factors and global trends of Tendonitis in the seven major markets (7MM: The United States, Germany, France, Italy, Spain, the United Kingdom, and Japan)
• The report provides insight about the historical and forecasted patient pool of Tendonitis in seven major markets covering the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.
• The report helps to recognize the growth opportunities in the 7MM concerning the patient population.
• The report assesses the disease risk and burden and highlights the unmet needs of Tendonitis.
• The report provides the segmentation of the Tendonitis epidemiology by total incident cases in the 7MM.
• The report provides the segmentation of the Tendonitis epidemiology by total gender-specific cases in the 7MM.
• The report provides the segmentation of the Tendonitis epidemiology by total region-specific cases in the 7MM.
• The report provides the segmentation of the Tendonitis epidemiology by total treated cases in the 7MM.
Report Highlights
• 10-Year Forecast of Tendonitis epidemiology
• 7MM Coverage
• Total incident Cases of Tendonitis
• Total gender-specific Cases of Tendonitis
• Total region-Specific Cases of Tendonitis
• Total treated Cases of Tendonitis
KOL-Views
We interview KOL’s and SME's opinion through primary research to fill the data gaps and validate our secondary research. The opinion helps to understand the total patient population and current treatment pattern. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the indications.
Key Questions Answered
• What will be the growth opportunities in the 7MM concerning the patient population of Tendonitis?
• What are the key findings of the Tendonitis epidemiology across the 7MM and which country will have the highest number of patients during the study period (2018–2030)?
• What would be the total number of patients with Tendonitis across the 7MM during the study period (2018–2030)?
• Among the EU5 countries, which country will have the highest number of patients during the study period (2018–2030)?
• At what CAGR the patient population is expected to grow in the 7MM during the study period (2018–2030)?
• What are the various recent and upcoming events which are expected to improve the diagnosis of Tendonitis?
Reasons to buy
The Tendonitis Epidemiology report will allow the user to -
• Develop business strategies by understanding the trends shaping and driving the global Tendonitis market
• Quantify patient populations in the global Tendonitis market to improve product design, pricing, and launch plans
• Organize sales and marketing efforts by identifying the gender that presents the best opportunities for Tendonitis therapeutics in each of the markets covered
• Understand the magnitude of the Tendonitis population by its age group-specificity
• The Tendonitis epidemiology report and model were written and developed by Masters and Ph.D. level epidemiologists
• The Tendonitis Epidemiology Model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based on transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over a 10-year forecast period using reputable sources
Key Assessments
• Patient Segmentation
• Disease Risk and Burden
• Risk of disease by the segmentation
• Factors driving growth in a specific patient population
Geographies Covered
• The United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan
Study Period: 2018–2030
• In the year 2020, the total incident case of Tendonitis was 11.71 million cases in the 7MM in 2020, which will probably rise during the study period, i.e., 2018–2030.
• In the 7MM, the total treated cases of Tendonitis was 5.47 million cases, which will probably rise during the study period, i.e., 2018–2030. In the 7MM, the highest number of treated cases of Tendonitis was observed in the US.
• In the 7MM, the total gender-specific cases of Tendonitis were 8.04 million cases (male), 3.68 million cases (female), respectively in 2020.
• In the 7MM, the total region-specific cases of Tendonitis were 3.45 million, 3.46 million, and 4.80 million cases for Achilles Tendonitis, Patellar Tendonitis, and others, respectively in 2020.